One in four dollars spent on health care in America now pays for unnecessary tests and treatments that physicians order to keep from being sued, according to a new Gallup poll of the nation's doctors.
One in four dollars spent on healthcare in America now pays for unnecessary tests and treatments that physicians order to keep from being sued, according to a new Gallup poll of the nation's doctors released by Jackson Healthcare and the Center for Health Transformation.
The poll showed that of physicians surveyed nationwide, 73% said they practiced some form of "defensive medicine" in the past 12 months to protect themselves from frivolous lawsuits. And insurers are footing the bills for the services, while directly or indirectly passing the costs on to enrollees and plan sponsors.
In the study, defensive medicine was defined as: "The practice of diagnostic or therapeutic measures conducted primarily not to ensure the health of the patient, but as a safeguard against possible malpractice liability." This may include tests, prescriptions, hospitalizations and referrals that may not be medically necessary.
"Healthcare would be cheaper for every American if we could slash the cost of defensive medicine," said Newt Gingrich, founder of the Center for Health Transformation (CHT) in a statement. "Think of how often each of us gets sent for extra lab work or tests that seem so unnecessary."
Gallup conducted the six-week, nationwide survey across all specialties of physicians. Those doctors reported that 26% of overall healthcare costs can be attributed to the practice of defensive medicine.
According to data from the Centers for Medicare and Medicaid Services, healthcare in America now costs $2.5 trillion annually.
CHT suggests addressing civil justice reform, or discouraging frivolous lawsuits, through several means including health courts that only consider medical malpractice cases.
Emerging Therapies Committee at UC Davis Hits the Accelerator Not the Brake | AMCP 2024
April 18th 2024After the onboarding of cell and gene therapy bogged using normal pharmacy and therapeutics (P&T) committee procedures, UC Davis Health set up an emerging therapeutics committee to streamline and speed up the process of delivery expensive cell and gene therapies.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
April 18th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More